Day1 Llc Ai serves as Executive at Day One Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Day1 Llc Ai has executed 3 insider transactions totaling $1.6M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 20, 2022 involved purchasing 4,615 shares valued at $68.0K.
Day1 Llc Ai currently holds 9,484,638 shares of Day One Biopharmaceuticals, Inc. (DAWN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Day1 Llc Ai has been a net buyer of DAWN stock. They have purchased $1.6M and sold $0 worth of shares.
Day1 Llc Ai's most recent insider trade was on Jan 20, 2022, when they purchased 4,615 shares at $14.73 per share.
Get notified when new Form 4 filings are submitted
| $14.70 |
| Discretionary |
| Jan 18, 2022 | DAWN | $619.3K | Purchase | 43,429 | $14.26 | Discretionary |